Changes to the Code
S. 3134 · Combating Counterfeit Pharmaceuticals Act of 2025 · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
21 U.S.C. § 2301 Sense of Congress
1 change the bill asks for here, 1 carried out
- Carried out:
in section 7202(3) (21 U.S.C. 2301(3)), by inserting
and other illicit drugs
afterfentanyl
;
§ 2301(2)–(3)
Start of § 2301 to (1) unchanged ·
(2) it is imperative that the People’s Republic of China follow through on full implementation of the new regulations, adopted May 1, 2019, to treat all fentanyl analogues as controlled substances under the laws of the People’s Republic of China, including by devoting sufficient resources for implementation and strict enforcement of the new regulations; and
(3) the effective enforcement of the new regulations should result in diminished trafficking of illicit fentanyl [inserted: and other illicit drugs ]originating from the People’s Republic of China into the United States.
21 U.S.C. § 2302 Definitions
10 changes the bill asks for here, 5 carried out
- Carried out:
by redesignating paragraphs (4) through (10) as paragraphs (5) through (11), respectively;
- Carried out:
by inserting after paragraph (3) the following:
(4) Copy-cat ingredient.— The term “copy-cat ingredient”, with respect to a drug, means an ingredient that is intended, including through the container or labeling of the ingredient, to mimic, knockoff, or otherwise purports to be a drug substance that is a component of a …
The section already has a provision under this letter or number, so it would have two.
- Carried out:
in the paragraph heading, by striking
opioid
and insertingillicit drug
; and - Carried out:
by striking
opioid
each place it appears and insertingillicit drug
; and - Carried out:
by striking paragraph (9), as so redesignated—
- Not carried out:
by striking paragraph (9), as so redesignated—
We can't read how this instruction is worded yet, so it isn't shown in the text.
Technical detail
no-pattern: as so redesignated — - Not carried out:
in the paragraph heading, by striking
Opioid
and insertingIllicit drug
;“Opioid” isn't in § 2302 in the Code as we have it. The law may have changed since the bill was drafted.
Technical detail
“Opioid” not found in /us/usc/t21/s2302 - Not carried out:
in the matter preceding subparagraph (A), by striking
opioid
and insertingillicit drug
; and“opioid” isn't in § 2302 in the Code as we have it. The law may have changed since the bill was drafted.
Technical detail
“opioid” not found in /us/usc/t21/s2302 - Not carried out:
in clause (i), by striking
; or
and inserting a semicolon;
andThe bill points to subparagraph (A) of § 2302, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.
Technical detail
target not found: no subparagraph (A) in /us/usc/t21/s2302 - Not carried out:
by adding at the end the following:
(iii) counterfeit drugs; or (iv) copy-cat ingredients;.
The bill points to subparagraph (A) of § 2302, which isn't there in the Code as we have it. It may have been renumbered or removed since the bill was drafted.
Technical detail
target not found: no subparagraph (A) in /us/usc/t21/s2302
This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.
§ 2302(2)–(11)
Start of § 2302 to (2)(A) unchanged ·
(B) the Committee on Appropriations, the Committee on Armed Services, the Committee on Financial Services, the Committee on Foreign Affairs, the Committee on Homeland Security, the Committee on the Judiciary, the Committee on Oversight and Reform, the Permanent Select Committee on Intelligence, and the Speaker and the minority leader of the House of Representatives.
(3) Controlled substance; listed chemical The terms “controlled substance”, “listed chemical”, “narcotic drug”, and “opioid” have the meanings given those terms in section 802 of this title.
(4) [inserted: Copy-cat ingredient.—] [inserted: The term “copy-cat ingredient”, with respect to a drug, means an ingredient that is intended, including through the container or labeling of the ingredient, to mimic, knockoff, or otherwise purports to be a drug substance that is a component of a prescription drug approved under section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) or licensed under section 351 of the Public Health Service Act (42 U.S.C. 262), and—]
(A) [inserted: the ingredient is manufactured by a different process than specified for the drug substance in the approval or licensure of the drug; or]
(B) [inserted: the purity or quality of the ingredient falls below that of the drug substance that is a component of the approved or licensed drug.]
(5) [inserted: Counterfeit drug.—] [inserted: The term “counterfeit drug” has the meaning given that term in section 201(g)(2) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(2)).]
[struck: (4)] [inserted: (5)] Entity The term “entity” means a partnership, joint venture, association, corporation, organization, network, group, or subgroup, or any form of business collaboration.
[struck: (5)] [inserted: (6)] Foreign [struck: opioid][inserted: illicit] [inserted: drug ]trafficker The term “foreign [struck: opioid][inserted: illicit] [inserted: drug ]trafficker” means—
(A) means 1 any foreign person that the President determines plays a significant role in [struck: opioid][inserted: illicit] [inserted: drug ]trafficking; and
(B) may 1 include—
(i) any entity of the People’s Republic of China that the President determines—
(I) produces, manufactures, distributes, sells, or knowingly finances or transports any goods described in clause (i) or (ii) of paragraph (8)(A); and
(II) demonstrates a pattern of failing to take credible steps (including implementing appropriate know-your-customer procedures or cooperating with United States counternarcotics efforts) to detect or prevent [struck: opioid][inserted: illicit] [inserted: drug ]trafficking; and
(ii) any senior official of the Government of the People’s Republic of China that—
(I) has significant regulatory or law enforcement responsibilities with respect to the activities of an entity described in clause (i); and
(II) aids and abets [struck: opioid][inserted: illicit] [inserted: drug ]trafficking.
[struck: (6)] [inserted: (7)] Foreign person The term “foreign person”—
(A) means—
(i) any citizen or national of a foreign country; or
(ii) any entity not organized under the laws of the United States or a jurisdiction within the United States; and
(B) does not include the government of a foreign country.
[struck: (7)] [inserted: (8)] Knowingly The term “knowingly”, with respect to conduct, a circumstance, or a result, means that a person has actual knowledge, or should have known, of the conduct, the circumstance, or the result.
[struck: (8)] [struck: Opioid trafficking] [struck: The term “opioid trafficking” means any illicit activity—]
[struck: (A)] [struck: to produce, manufacture, distribute, sell, or knowingly finance or transport—]
[struck: (i)] [struck: synthetic opioids, including controlled substances that are synthetic opioids and listed chemicals that are synthetic opioids; or]
[struck: (ii)] [struck: active pharmaceutical ingredients or chemicals that are used in the production of controlled substances that are synthetic opioids;]
[struck: (B)] [struck: to attempt to carry out an activity described in subparagraph (A); or]
[struck: (C)] [struck: to assist, abet, conspire, or collude with other persons to carry out such an activity.]
[struck: (9)] [inserted: (10)] Person The term “person” means an individual or entity.
[struck: (10)] [inserted: (11)] United States person The term “United States person” means—
(A) any citizen or national of the United States;
(B) any alien lawfully admitted for permanent residence in the United States;
(C) any entity organized under the laws of the United States or any jurisdiction within the United States (including a foreign branch of such an entity); or
(D) any person located in the United States.
21 U.S.C. § 2311 Identification of foreign opioid traffickers
2 changes the bill asks for here, 2 carried out
- Carried out:
Section 7211 of the Fentanyl Sanctions Act (21 U.S.C. 2311) is amended, in subsections (d) and (e), by inserting
(or a designee of the Director)
afterDirector of National Intelligence
each place it appears. - Carried out:
in section 7211 (21 U.S.C. 2311), in the section heading, by striking
opioid
and insertingillicit drug
;
§ 2311(a)
§ 2311. Identification of foreign [struck: opioid][inserted: illicit] [inserted: drug ]traffickers
(a) Public report
(1) In general The President shall submit to the appropriate congressional committees and leadership, in accordance with subsection (c), a report—
§ 2311(c)–(d)
(a)(1)(A)–(b)(2) unchanged ·
(c) Submission of reports Not later than 180 days after December 20, 2019, and annually thereafter until December 31, 2030, the President shall submit the reports required by subsections (a) and (b) to the appropriate congressional committees and leadership.
(d) Exclusion of certain information
(1) Intelligence Notwithstanding any other provision of this section, a report required by subsection (a) or (b) shall not disclose the identity of any person if the Director of National Intelligence [inserted: (or a designee of the Director) ]determines that such disclosure could compromise an intelligence operation, activity, source, or method of the United States.
(2) Law enforcement Notwithstanding any other provision of this section, a report required by subsection (a) or (b) shall not disclose the identity of any person if the Attorney General, in coordination, as appropriate, with the Director of the Federal Bureau of Investigation, the Administrator of the Drug Enforcement Administration, the Secretary of the Treasury, the Secretary of State, and the head of any other appropriate Federal law enforcement agency, determines that such disclosure could reasonably be expected—
(A) to compromise the identity of a confidential source, including a State, local, or foreign agency or authority or any private institution that furnished information on a confidential basis;
§ 2311(d)–(e)
(d)(2)(B)–(C) unchanged ·
(D) to cause substantial harm to physical property.
(3) Notification required If the Director of National Intelligence [inserted: (or a designee of the Director) ]makes a determination under paragraph (1) or the Attorney General makes a determination under paragraph (2), the Director or the Attorney General, as the case may be, shall notify the appropriate congressional committees and leadership of the determination and the reasons for the determination.
(4) Rule of construction Nothing in this section may be construed to authorize or compel the disclosure of information determined by the President to be law enforcement information, classified information, national security information, or other information the disclosure of which is prohibited by any other provision of law.
(e) Provision of information required for reports The Secretary of the Treasury, the Attorney General, the Secretary of Defense, the Secretary of State, the Secretary of Homeland Security, and the Director of National Intelligence [inserted: (or a designee of the Director) ]shall consult among themselves and provide to the President and the Director of the Office of National Drug Control Policy the appropriate and necessary information to enable the President to submit the reports required by subsection (a).
21 U.S.C. § 2314 Waivers
3 changes the bill asks for here, 3 carried out
- Carried out:
Section 7214(b)(1)(B) of the Fentanyl Sanctions Act (21 U.S.C. 2314(b)(1)(B)) is amended by inserting after
medications
the following:on the current drug shortage list maintained by the Secretary of Health and Human Services under section 506E of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 356e)
. - Carried out:
in subsection (a)(2)(B)(ii), by striking
opioids
and insertingillicit drugs
; and - Carried out:
in subsection (b)(2), by striking
illicit opioids
and insertingillicit drugs
;
§ 2314(a)(2)(B)doing two or more of the following:(i)–(iv)
Start of § 2314 to (a)(2)(B) unchanged ·
(i) Implementing substantial improvements in regulations involving the chemical and pharmaceutical production and export of illicit opioids.
(ii) Implementing substantial improvements in judicial regulations to combat transnational criminal organizations that traffic [struck: opioids][inserted: illicit drugs].
(iii) Increasing efforts to prosecute foreign opioid traffickers.
(iv) Increasing intelligence sharing and law enforcement cooperation with the United States with respect to opioid trafficking.
§ 2314(b)–(c)
(a)(3)–(b)(1) unchanged ·
(A) the national security interests of the United States; or
(B) subject to paragraph (2), the access of United States persons to prescription medications[inserted: on the current drug shortage list maintained by the Secretary of Health and Human Services under section 506E of the Federal Food, Drug, and Cosmetic Act (21 U].[inserted: S.C. 356e).]
(2) Monitoring The President shall establish a monitoring program to verify that a person that receives a waiver under paragraph (1)(B) is not trafficking illicit [struck: opioids][inserted: drugs].
(3) Notification Not later than 15 days after making a determination under paragraph (1), the President shall notify the appropriate congressional committees and leadership of the determination and the reasons for the determination.
(c) Humanitarian waiver The President may waive, for renewable periods of 180 days, the application of the sanctions under this subchapter if the President certifies to the appropriate congressional committees and leadership that the waiver is necessary for the provision of humanitarian assistance.
21 U.S.C. § 2316 Briefings on implementation
1 change the bill asks for here, 1 carried out
- Carried out:
Section 7216 of the Fentanyl Sanctions Act (21 U.S.C. 2316) is amended by inserting
(or a designee of the Director)
afterDirector of National Intelligence
.
§ 2316
§ 2316. Briefings on implementation
Not later than 90 days after December 20, 2019, and every 180 days thereafter until the date that is 5 years after December 20, 2019, the President, acting through the Secretary of State and the Director of National Intelligence[inserted: (or a designee of the Director)], in coordination with the Secretary of the Treasury, shall provide to the appropriate congressional committees and leadership a comprehensive briefing on efforts to implement this subchapter.
21 U.S.C. § 2331 Director of National Intelligence program on use of intelligence resources in efforts to sanction foreign opioid traffickers
5 changes the bill asks for here, 5 carried out
- Carried out:
in the section heading, by striking
opioid
and insertingillicit drug
; - Carried out:
in paragraph (1), by striking
, in consultation
and all that follows throughPolicy,
; and - Carried out:
in paragraph (2)(A), by striking
narcotics
and insertingillicit drug
; - Carried out:
by striking subsections (b) and (c); and
- Carried out:
by redesignating subsection (d) as subsection (b).
§ 2331(a)–(b)
§ 2331. Director of National Intelligence program on use of intelligence resources in efforts to sanction foreign [struck: opioid][inserted: illicit] [inserted: drug ]traffickers
(a) Program required
(1) In general The Director of National Intelligence shall[struck: ,] [struck: in consultation with the Director of the Office of National Drug Control Policy, ]carry out a program to allocate and enhance use of resources of the intelligence community, including intelligence collection and analysis, to assist the Secretary of the Treasury, the Secretary of State, and the Administrator of the Drug Enforcement Administration in efforts to identify and impose sanctions with respect to foreign opioid traffickers under subchapter I.
(2) Focus on illicit finance To the extent practicable, efforts described in paragraph (1) shall—
(A) take into account specific illicit finance risks related to [struck: narcotics][inserted: illicit] [inserted: drug ]trafficking; and
(B) be developed in consultation with the Undersecretary of the Treasury for Terrorism and Financial Crimes, appropriate officials of the Office of Intelligence and Analysis of the Department of the Treasury, the Director of the Financial Crimes Enforcement Network, and appropriate Federal law enforcement agencies.
[struck: (b)] [struck: Review of counternarcotics efforts of the intelligence community] [struck: The Director of National Intelligence shall, in coordination with the Director of the Office of National Drug Control Policy, carry out a comprehensive review of the current intelligence collection priorities of the intelligence community for counternarcotics purposes in order to identify whether such priorities are appropriate and sufficient in light of the number of lives lost in the United States each year due to use of illegal drugs.]
[struck: (c)] [struck: Reports and briefings]
[struck: (1)] [struck: Reports and briefings on program]
[struck: (A)] [struck: Annual reports] [struck: Not later than 90 days after December 20, 2019, and annually thereafter, the Director of National Intelligence and the Director of the Office of National Drug Control Policy shall jointly submit to the appropriate congressional committees and leadership a report on the status and accomplishments of the program required by subsection (a) during the year ending on the date of the report. The first report under this subparagraph shall also include a description of the amount of funds devoted by the intelligence community to the efforts described in subsection (a) during each of fiscal years 2017 and 2018.]
[struck: (B)] [struck: Semiannual briefings] [struck: On a semiannual basis, the Director of National Intelligence and the Director of the Office of National Drug Control Policy shall jointly brief the appropriate congressional committees and leadership on the status and accomplishments of the program required by subsection (a).]
[struck: (2)] [struck: Report on review] [struck: Not later than 120 days after December 20, 2019, the Director of National Intelligence, in consultation with the Director of the Office of National Drug Control Policy and other relevant agencies, shall submit to the appropriate congressional committees and leadership—]
[struck: (A)] [struck: a comprehensive description of the results of the review required by subsection (b); and]
[struck: (B)] [struck: an assessment of whether—]
[struck: (i)] [struck: the priorities described in that subsection are appropriate and sufficient in light of the number of lives lost in the United States each year due to use of illegal drugs; and]
[struck: (ii)] [struck: any changes to such priorities are necessary.]
[struck: (d)] [inserted: (b)] Intelligence community defined In this section, the term “intelligence community” has the meaning given that term in section 3003(4) of title 50.
21 U.S.C. § 2333 Regulatory authority
1 change the bill asks for here, 1 carried out
- Carried out:
in section 7233 (21 U.S.C. 2333), by striking
section 7203(8)
and insertingsection 7203(9)
;
§ 2333
§ 2333. Regulatory authority
Not later than 90 days after December 20, 2019, the President shall issue such regulations as are necessary to carry out this chapter, including guidance with respect to what activities are included under the definition of “opioid trafficking” under section [struck: 2302][inserted: 7203]([struck: 8][inserted: 9])[struck: of this title].
22 U.S.C. § 2291h Reporting requirements
2 changes the bill asks for here, 2 carried out
- Carried out:
in subparagraph (A), by inserting
(or a designee of the Director)
afterDirector of National Intelligence
; and - Carried out:
by striking
illicit opioids
each place it appears and insertingillicit drugs
.
§ 2291h(a)International narcotics control strategy report(8)–(11)
Start of § 2291h to (a)(8)(B)(i) unchanged ·
(ii) The best available data and other information regarding the production of methamphetamine in such countries and the diversion of such chemicals for use in the production of methamphetamine.
(9)
(A) An assessment conducted by the Secretary of State, in consultation with the Secretary of the Treasury and the Director of National Intelligence[inserted: (or a designee of the Director)], of the extent to which any diplomatic efforts described in section 7217(a) of the Fentanyl Sanctions Act have been successful.
(B) Each assessment required by subparagraph (A) shall include an identification of—
(i) the countries the governments of which have agreed to undertake measures to apply economic or other financial sanctions to foreign traffickers of illicit [struck: opioids][inserted: drugs] and a description of those measures; and
(ii) the countries the governments of which have not agreed to measures described in clause (i), and, with respect to those countries, other measures the Secretary of State recommends that the United States take to apply economic and other financial sanctions to foreign traffickers of illicit [struck: opioids][inserted: drugs].
(10) A separate section that contains an identification of all United States Government-supported units funded by the Bureau of International Narcotics and Law Enforcement Affairs and any Bureau-funded operations by such units in which United States law enforcement personnel have been physically present.
(11) A separate section that contains the following:
Rest of § 2291h unchanged ·